患有急性至慢性肝衰竭的患者体外肝支持系统:更新的系统性审查和元分析
Haiyu Liu1, Zhibo Yang2, Qiong Luo3
1Department of Pulmonary and Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, China.
Artificial organs
|November 23, 2024
概括
与标准治疗相比,体外肝支持系统提高了急性-慢性肝功能衰竭患者的生存率,并减少了与标准治疗相比的并发症. 这些好处在MELD得分和胆红素水平较低的患者中更为明显.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 关键护理医学 关键护理医学
- 医疗技术 医疗技术 医学技术
背景情况:
- 急性至慢性肝衰竭 (ACLF) 的管理通常涉及体外肝支持系统 (ECLS).
- 对ACLF患者ECLS的临床有效性仍在研究中,需要严格分析.
研究的目的:
- 进行一项元分析,评估ECLS与ACLF的标准药理疗法.
- 评估ECLS对患者生存和关键并发症的影响.
主要方法:
- 使用PubMed,EMBASE和Web of Science的文献进行了更新的元分析.
- 预后终点包括1个月和3个月死亡率.
- 分析了肝脏脑病变,自发性细菌周周炎和肝综合征的发生率.
主要成果:
- ECLS显著降低了1个月 (OR 0.63) 和3个月的死亡率 (OR 0.70).
- 通过ECLS,降低了肝脏脑病变 (OR 0.81),自发性细菌性腹膜炎 (OR 0.66),肝综合征 (OR 0.68) 的发生率.
- 亚组分析显示,MELD得分和总胆红素水平较低的患者的益处更大.
结论:
- 外体肝支持系统为ACLF患者提供了生存优势.
- 与标准药物治疗相比,ECLS治疗与严重并发症的发生率降低有关.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
377
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
377
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414
Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42


